Thierry Kimmerlin

1.0k total citations
20 papers, 869 citations indexed

About

Thierry Kimmerlin is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thierry Kimmerlin has authored 20 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Organic Chemistry and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thierry Kimmerlin's work include Chemical Synthesis and Analysis (13 papers), Click Chemistry and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Thierry Kimmerlin is often cited by papers focused on Chemical Synthesis and Analysis (13 papers), Click Chemistry and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Thierry Kimmerlin collaborates with scholars based in Switzerland, Austria and Germany. Thierry Kimmerlin's co-authors include Dieter Seebàch, Daniël Hoyer, Karl Gademann, Magnus Rueping, Albert K. Beck, Radovan Šebesta, Marino A. Campo, Daniel Langenegger, Martin Hintersteiner and Manfred Auer and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Thierry Kimmerlin

19 papers receiving 852 citations

Peers

Countries citing papers authored by Thierry Kimmerlin

Since Specialization

Citations

This map shows the geographic impact of Thierry Kimmerlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Kimmerlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Kimmerlin more than expected).

Fields of papers citing papers by Thierry Kimmerlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Kimmerlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Kimmerlin. The network helps show where Thierry Kimmerlin may publish in the future.

Co-authorship network of co-authors of Thierry Kimmerlin

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Kimmerlin. A scholar is included among the top collaborators of Thierry Kimmerlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Kimmerlin. Thierry Kimmerlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational Simulations 2025 ·Journal of Medicinal Chemistry ·(unknown), Thierry Kimmerlin, A. Mac Sweeney, (unknown), Roland Lange, Daniel Ritz, Sylvia Richard‐Bildstein, (unknown), Paul Czodrowski	0
2	Discovery and binding mode of small molecule inhibitors of the apo form of human TDO2 2024 ·Scientific Reports ·(unknown), Roland Lange, (unknown), (unknown), (unknown), Thierry Kimmerlin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), A. Mac Sweeney	1
3	The Screening Compound Collection: A Key Asset for Drug Discovery 2017 ·CHIMIA International Journal for Chemistry ·Christoph Boss, (unknown), Thierry Kimmerlin, Modest von Korff, Urs Lüthi, O Péter, Thomas Sander, Romain Siegrist	16
4	Discovery and Optimization of Isoquinoline Ethyl Ureas as Antibacterial Agents 2017 ·Journal of Medicinal Chemistry ·Philippe Panchaud, Thierry Bruyère, (unknown), Daniel Bur, (unknown), Eric A. Ertel, Markus Gude, Christian Hubschwerlen, (unknown), Thierry Kimmerlin, Thomas Pfeifer, Lars Prade, Peter Seiler, Daniel Ritz, Georg Rueedi	80
5	Single Bead Labeling Method for Combining Confocal Fluorescence On-Bead Screening and Solution Validation of Tagged One-Bead One-Compound Libraries 2009 ·Chemistry & Biology ·Martin Hintersteiner, Thierry Kimmerlin, Frank Kalthoff, Markus Stoeckli, Géraldine Garavel, Jan‐Marcus Seifert, Nicole Meisner‐Kober, Volker Uhl, Christof Buehler, Thomas Weidemann, Manfred Auer	53
6	A Highly Potent and Cellularly Active β‐Peptidic Inhibitor of the p53/hDM2 Interaction 2009 ·ChemBioChem ·Martin Hintersteiner, Thierry Kimmerlin, Géraldine Garavel, (unknown), Roman Bauer, Nicole Meisner‐Kober, Jan‐Marcus Seifert, Volker Uhl, Manfred Auer	20
7	Covalent Fluorescence Labeling of His‐Tagged Proteins on the Surface of Living Cells 2008 ·ChemBioChem ·Martin Hintersteiner, Thomas Weidemann, Thierry Kimmerlin, (unknown), Christof Buehler, Manfred Auer	28
8	Investigation of the Interactions of β‐Peptides with DNA Duplexes by Circular Dichroism Spectroscopy 2006 ·Helvetica Chimica Acta ·Kenji Namoto, James Gardiner, Thierry Kimmerlin, Dieter Seebàch	11
9	‘100 years of peptide synthesis’: ligation methods for peptide and protein synthesis with applications to β‐peptide assemblies* 2005 ·Journal of Peptide Research ·Thierry Kimmerlin, Dieter Seebàch	150
10	Preparation ofβ2-Amino Acid Derivatives (β2hThr,β2hTrp,β2hMet,β2hPro,β2hLys, Pyrrolidine-3-carboxylic Acid) by Using DIOZ as Chiral Auxiliary 2005 ·Helvetica Chimica Acta ·F. Gessier, Laurent Schaeffer, Thierry Kimmerlin, Oliver Flögel, Dieter Seebàch	22
11	NMR‐Solution Structures in Methanol of an α‐Heptapeptide, of a β³/β²‐Nonapeptide, and of an all‐β³‐Icosapeptide Carrying the 20 Proteinogenic Side Chains 2005 ·Helvetica Chimica Acta ·Dieter Seebàch, (unknown), Thierry Kimmerlin, Yogesh R. Mahajan, P. Bindschädler, Magnus Rueping, Bernhard Jaun, Christian Hilty, (unknown)	28
12	Comparative Metabolism of α‐ and β‐Peptides in the Insect Heliothis virescens and in Plant Cells of Black Mexican Sweet Maize 2004 ·Chemistry & Biodiversity ·Rob Lind, (unknown), (unknown), Thierry Kimmerlin, Dieter Seebàch	20
13	Pharmacokinetic Investigation of a ¹⁴C‐Labelled β³/α Tetrapeptide in Rats 2004 ·Chemistry & Biodiversity ·(unknown), B. Wirz, Alain Schweitzer, Gerhard Groß, (unknown), Hendrik Andres, Thierry Kimmerlin, Magnus Rueping, Dieter Seebàch	38
14	How we drifted into peptide chemistry and where we have arrived at 2004 ·Tetrahedron ·Dieter Seebàch, Thierry Kimmerlin, Radovan Šebesta, Marino A. Campo, Albert K. Beck	96
15	Solid‐Phase Synthesis of a β³‐Icosapeptide Containing the Homologs of the Twenty Common Proteinaceous Amino Acids. Preliminary Communication 2003 ·Helvetica Chimica Acta ·Thierry Kimmerlin, Dieter Seebàch	13
16	β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors 2003 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Caroline Nunn, Magnus Rueping, Daniel Langenegger, (unknown), Thierry Kimmerlin, (unknown), Konstanze Hurth, Dieter Seebàch, Daniël Hoyer	41
17	Evidence from Circular Dichroism and from Melting Behavior for Helix‐Inducing Complexation of a Designed β³‐Pentadecapeptide with DNA Duplexes. Preliminary Communication 2003 ·Helvetica Chimica Acta ·Thierry Kimmerlin, Kenji Namoto, Dieter Seebàch	8
18	Synthesis ofβ3-Peptides and Mixedα/β3-Peptides by Thioligation 2002 ·Helvetica Chimica Acta ·Thierry Kimmerlin, Dieter Seebàch, Donald Hilvert	34
19	Linear, Peptidase-Resistantβ2/β3-Di- andα/β3-Tetrapeptide Derivatives with Nanomolar Affinities to a Human Somatostatin Receptor, Preliminary Communication 2001 ·Helvetica Chimica Acta ·Dieter Seebàch, Magnus Rueping, Per I. Arvidsson, Thierry Kimmerlin, (unknown), Christian Noti, Daniel Langenegger, Daniël Hoyer	66
20	Peptide Folding Induces High and Selective Affinity of a Linear and Small β-Peptide to the Human Somatostatin Receptor 4 2001 ·Journal of Medicinal Chemistry ·Karl Gademann, Thierry Kimmerlin, Daniël Hoyer, Dieter Seebàch	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact